Skip to main content

Table 5. Interventional and pharmacological therapies during hospitalization of NSTE-ACS patients.

Registry 1 (2008-2010) Registry 2 (2012-2015) p value
(n = 975) (n = 1062)
Interventional therapies
 Door to ECG time (min) 13 (7-31) 9 (5-75) 0.4834
 First ECG within 10 min  35.9%   48.5%  < 0.0001
 D2B time (min) 2534 (260-3367) 2003 (1016-4167) 0.0048
 Left main intervention  3.8%   5.6%  0.0496
 No. of lesion treated > 2  12.6%   22.2%  < 0.0001
 DES  35.1%   62.9%  < 0.0001
 CABG  0.9%   0.3%  0.0598
Pharmacological therapies
 Aspirin  89.7%   99.3%  < 0.0001
 Clopidogrel  93.3%   99.6%  < 0.0001
 Dual antiplatelet therapy  85.5%   99.0%  < 0.0001
 GP 2b3a inhibitor  9.1%   8.5%  0.6027
 Heparin  65.5%   85.5%  < 0.0001
 ACEI/ARB  58.3%   67.6%  < 0.0001
 Beta blocker  43.3%   64.4%  < 0.0001
 Statin  48.0%   78.8%  < 0.0001
 Calcium channel antagonist  15.3%   26.2%  < 0.0001
 Nitrate  69.3%   59.8%  < 0.0001
 Oral anticoagulant  0.6%   3.7%  < 0.0001

Abbreviations as the Table 2.